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Abstract
Familial adenomatous polyposis (FAP) is usually caused by germline mutations in the adenomatous polyposis coli (APC) 
gene. The classic form is characterized by hundreds to thousands of adenomas in the colorectum and early onset colorectal 
cancer (CRC) if left untreated. FAP is also associated with multiple extra-colonic manifestations such as gastroduodenal 
polyps, osteomas, epidermoid cysts, fibromas and desmoids. Most desmoid tumours in FAP patients occur intra-abdominally. 
Approximately 15–20% of the APC mutations are de novo mutations. Somatic mosaicism has been reported in some spo-
radic cases of polyposis but is probably an underestimated cause of the disease. This case report presents the detection of a 
mosaic APC mutation in a 26-year-old woman who as a child had been diagnosed with desmoid type fibromatosis. FAP was 
suggested when she presented with extensive extra abdominal fibromatosis. Our findings indicate that APC mutations may 
be suspected in patients presenting with a desmoid regardless of its location. If there is clinical evidence that the patient has 
FAP, adenomas and colonic mucosa in addition to leukocyte DNA should be included in the screening, preferably using 
methods that are more sensitive than Sanger sequencing.
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Introduction
Familial adenomatous polyposis (FAP) is a rare autosomal 
dominant disorder caused by mutations in the Adenoma-
tous Polyposis Coli (APC) gene. The classic form of FAP is 
characterized by the development of hundreds to thousands 
of adenomas in the colon and rectum from a young age [1]. 
Without surgical intervention patients have an almost 100% 
risk of developing colorectal cancer (CRC) before the age of 
40–50 years [2]. Gastric fundic gland polyps are present in 
most FAP patients but rarely progress to cancer [3]. Duode-
nal adenomas are found in a majority of patients. Prospective 
studies evaluating the effect of endoscopic screening have 
showed a 5–18% lifetime risk for duodenal cancer [4–6]. 
There is a slightly increased risk of other malignancies such 
as cancer of the thyroid, liver, pancreas and in the central 
nervous system. FAP is also associated with extra-gastroin-
testinal manifestations such as dental abnormalities, osteo-
mas and soft tissue tumours like epidermoid cysts, Gardner 
fibromas and desmoid tumours [7].
Attenuated FAP (AFAP) is characterized by a milder phe-
notype with fewer adenomas (< 100), a proximal location of 
colonic lesions and a later onset of both adenomas and CRC 
[8]. Extra-gastrointestinal manifestations are rare [8].
Approximately 15–20% of FAP cases are caused by de 
novo APC mutations [9] and 20% of these have somatic 
mosaicism [10]. The extent of both colonic and extra-colonic 
manifestations depends on the degree and distribution of 
the mutation in the different tissues. Somatic mosaicism is 
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difficult to detect and is probably an underestimated cause 
of the disease [10].
A genotype–phenotype correlation is documented in 
FAP, but it is not consistent. Classical or severe polyposis is 
associated with mutations between codons 1250–1464 and 
desmoids with mutations throughout the whole gene, but 
probably more severe after codon 1444 [11–13]. AFAP is 
associated with mutations before codon 157, in the alter-
natively spliced region of exon 9 and after codon 1595 
[11–13]. There is considerable phenotypic variability within 
and between families. Used with caution, the correlation is 
one of several factors considered when deciding on follow-
up, timing of surgery and type of surgery.
Ten to 30% of FAP patients have desmoids and the major-
ity occur within the abdomen or in the abdominal wall 
[14–16]. Desmoids can develop at any age but the incidence 
is highest in the second and third decades of life [16, 17]. 
Several studies confirm that a family history of desmoids, 
previous abdominal surgery and, more debated, an APC 
pathogenic mutation at the 3′ end of the gene, are predictors 
for desmoid tumour development [14, 16, 17]. Most cases of 
desmoid type fibromatosis are sporadic; but in 5–16% they 
are associated with FAP [14, 15, 18].
Here we report the detection of a somatic mosaic APC 
mutation in a patient who was diagnosed with desmoid type 
fibromatosis in childhood. FAP was eventually suggested 
after she developed extensive extra-abdominal fibromatosis.
Case presentation
A 26-year-old female was referred to the Sarcoma group at 
Oslo University Hospital with a large soft tissue lesion in her 
left thigh, described histologically as inactive fibromatosis. 
MRI-findings were consistent with this diagnosis. Subcuta-
neous soft tissue tumours were detected in her right buttock 
and along the spine. Histologically a surgical biopsy from 
one of these lesions was described as fibrous tissue but not 
fibromatosis. It was suggested that it could be a Gardner 
fibroma. The patient reported some pain in her hip and back.
She had been diagnosed with desmoid type fibromatosis 
as a child following removal of several subcutaneous soft 
tissue tumours and epidermoid cysts. The initial tumour was 
detected when she was 2 months old. Three tumours were 
removed during her first year and nine tumours were subse-
quently removed before she turned three. Neurofibromato-
sis was considered as a differential diagnosis but as she did 
not have any café-au-lait spots, this diagnosis was excluded. 
Over the years she had several small lesions removed. Biop-
sies revealed epidermoid cysts and fibromatous tissue.
Based on her medical history, FAP was suggested and 
upper and lower endoscopic examinations were performed. 
Some fifty adenomas were detected throughout her colon but 
predominantly in the distal part. Biopsies showed low-grade 
dysplasia. In her stomach, 50–70 fundic gland polyps and 
some adenomas were detected and one adenoma with low-
grade dysplasia was detected in the duodenum. Phenotypi-
cally she had a mild colon polyposis. There was no history 
of fibromatosis, polyps or CRC in her close family. She was 
referred to genetic counselling and testing.
Germline testing of the APC gene was initially performed 
utilizing Sanger sequencing and Multiplex Ligation-depend-
ent Probe Amplification Analysis. Sanger sequencing of leu-
kocyte DNA from peripheral blood indicated presence of a 
pathogenic mutation, c.4348C > T (p.Arg1450*), in the APC 
gene. The signal representing the mutation was very weak, 
indicating somatic mosaicism. DNA was extracted from 
normal colonic mucosa and from adenoma tissue. Sanger 
sequencing revealed significantly higher levels of the muta-
tion in these tissues compared to the blood sample (Fig. 1). 
After the initial investigation we were able to perform next 
generation sequencing (NGS) of a cancer gene panel library 
(Illumina TruSight cancer Sequencing panel). This showed 
that the frequency of the mutation varied among different 
tissue types, and hence confirmed somatic mosaicism of the 
APC mutation in the patient.
Her parents and siblings were tested but did not have the 
mutation, consistent with a de novo origin of the mutation.
The mutation in this patient affected codon 1450, a site 
of the APC gene associated with classical polyposis and 
desmoid development. Based on her high risk of CRC, 
prophylactic proctocolectomy was recommended, and she 
underwent laparoscopic proctocolectomy with an ileal pouch 
and ileoanal anastomosis without diverting ileostomy. She 
has been followed with regular endoscopic examinations of 
the ileal pouch and oesophagogastroduodenoscopy is per-
formed every 6 months due to duodenal adenomas.
Abdominal MRI 9 months post surgery was unremark-
able. A year later, less than 2 years after surgery, she pre-
sented with three desmoids. Two were located in the abdom-
inal wall (laparoscopy port site and Pfannenstiel incision) 
and the third intra-abdominally in the mesentery.
MRI 6 and 9 months later showed desmoid progression. 
However, due to the risk of triggering a more aggressive 
course of the disease and the unlikeliness of a radical exci-
sion, a “wait and see” approach was adopted. MRI, taken 
almost 3 years after surgery, showed that the desmoids had 
remained stable. However, since then, the latest MRI has 
shown that the lesions have grown.
Discussion
In FAP, soft tissue tumours like desmoids and epidermoid 
cysts may present before the appearance of colon polyps [15, 
19]. Several studies have demonstrated that asymptomatic 
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patients who have extra-truncal desmoids, are less likely to 
have FAP [14, 15, 18], and that in FAP patients, most of 
the desmoids are located in the abdominal cavity/abdomi-
nal wall [14–16]. Testing of the APC gene and/or colonos-
copy to rule out FAP is therefore not performed routinely 
in patients with extra-abdominal desmoids. This patient ini-
tially only had extra-truncal fibromatosis and FAP was not 
considered before she had more extensive fibromatosis in 
her buttock and along her spine.
There are several reports of patients and families with 
desmoids, with none or a few polyps, but who harbour a 
mutation after codon 1900 in the 3′ end of the APC gene 
[20–22]. Our patient had her first colonoscopy at 26 years 
of age and had fewer colon polyps than expected according 
to the site of her mutation. A colonoscopy done 10–15 years 
earlier would perhaps have missed the diagnosis, as she may 
not have developed polyps at that time. Our case illustrates 
that FAP may be suspected in patients with only extra-
abdominal desmoids, and that not only colonoscopy but also 
genetic testing of the APC gene should be offered to these 
patients. Previous studies have already suggested testing for 
APC mutations in children with extracolonic manifestations 
as hepatoblastoma, osteoma and Gardner fibroma [11, 19, 
23].
A de novo APC gene mutation was anticipated, as 
there was no family history of desmoids, polyps or CRC. 
Sanger sequencing revealed very weak signals represent-
ing the mutation in leukocyte DNA, and could have been 
missed. However, since mosaicism is not infrequent in FAP, 
sequencing DNA from one of her adenomas and her colonic 
mucosa followed up the analyses. This revealed stronger sig-
nals representing the mutation, suggests an early postzygotic 
mutational event involving both the endoderm (adenoma) 
and the mesoderm (blood) and shows the importance of 
including adenomas and colonic mucosa in the screening. 
Other screening methods including NGS have shown higher 
sensitivity than Sanger sequencing in detecting low level 
APC-mutation mosaicism [10, 24, 25]. A substantial number 
of mosaic cases may be missed when doing Sanger sequenc-
ing of blood (leukocyte DNA) [10, 24, 25]. Several studies 
have demonstrated that adenomas should be included in the 
screening for low level APC mosaicism as a high frequency 
of cases are not detectable in leukocyte DNA [10, 24, 25]. 
A recent publication underlines the importance of testing 
multiple adenomas as co-occurence of sporadic adenomas 
within a mosaic environment has been reported [26]. Our 
study also highlights the power of NGS in identifying and 
characterizing somatic mosaicism in various tissues.
The APC gene mutation in our patient affecting codon 
1450 is in the mutation cluster region of the APC gene. This 
position is at the site for classical FAP, desmoids, osteomas 
and epidermoid cysts. Despite this, the patient had an attenu-
ated colon polyposis with approximately 50 colon adenomas. 
But contrary to AFAP, the adenomas had a predominantly 
distal location in the colon. Her upper gastrointestinal find-
ings were in accordance with what can be seen both in FAP 
and AFAP. Several studies have shown that somatic mosai-
cism for APC pathogenic variants usually associated with 
classic FAP may express a milder colon polyposis phenotype 
[10, 24, 25]. In these studies, there was only one patient with 
a desmoid tumour [10]. In our patient, the first fibromatous 
lesion was noted when she was 2 months old; she had several 
others over the years and massive fibromatosis in her thigh, 
buttock and back at the time she was diagnosed with FAP. 
Some reports have shown a higher incidence of epidermoid 
cysts and a more severe desmoid disease in patients with 
Fig. 1  Sequence analysis of 
the APC mutation c.4348C > T 
(p.Arg1450*) in peripheral 
blood, normal colonic tissue 
and adenoma tissue from 
the patient. The fraction of 
NGS reads representing the 
c.4348C > T mutation is shown 
to the left
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a mutation between codon 1445 and codon 1580 than in 
patients with mutations in other regions of the APC gene 
[27–29]. Her mild colon polyposis and severe fibromatosis 
may therefore be explained by varying distribution of the 
mutation in different tissues. Additional genetic and envi-
ronmental factors may also have an influence.
Prophylactic surgery at an early age is recommended 
in patients with FAP. Surgery is known to be a trigger of 
desmoid formation, and postponing surgery in patients at 
risk of developing desmoids could be advocated. In our 
opinion, such a policy cannot be justified as malignant 
transformation can occur even under close surveillance. 
Unfortunately, our patient developed intra-abdominal and 
abdominal wall desmoids shortly after surgery and she is 
now in a “wait and see” situation as desmoids can regress, 
remain stable or progress, in which case medical treatment 
could be considered.
Although identification of an APC mutation confirmed 
a FAP diagnosis for this patient, genetic counselling in this 
situation is difficult. For patients carrying germline muta-
tions, offspring will have a 50% chance of inheriting the 
mutation. However, when there is somatic mosaicism the 
risk depends on the level of mosaicism in the patient´s germ 
cells [10, 30]. Germline mosaicism in an unaffected parent 
of children with colonic adenomatous polyposis has been 
reported [10, 31]. Another counselling issue is that the off-
spring will most likely have a more severe phenotype than 
the affected parent [25].
We counselled our patient not to become pregnant and 
give birth, primarily because her pelvic pouch would prob-
ably necessitate a caesarean section, which would put her at 
increased risk of abdominal desmoids. The natural history 
of her disease has proved this to be sound advice.
Conclusion
Our case illustrates that a history of extra-abdominal 
fibromatosis may be an indication for colonoscopy and APC 
genetic testing, and that APC mosaicism may be the cause 
of not just single cases of polyposis but also of the extra-
colonic features of FAP. Adenomas and colonic mucosa in 
addition to leukocyte DNA should be included in the screen-
ing, preferably using NGS, if there is a suspicion of FAP.
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